MedTrace Logo

LV Thrombus Screening in Anterior STEMI: Worth it?

NCT06480929 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2024-06-28

No results posted yet for this study

Summary

Left ventricular (LV) thrombus is more common in patients with anterior ST-elevation myocardial infarction (STEMI) compared to other types of acute myocardial infarction (AMI) and is linked to worse outcomes. Diagnosing LV thrombus remains challenging. Contrast echocardiography (TTE) has potential to improve diagnostic accuracy, affecting treatment strategies involving antithrombotic/anticoagulation therapy.

This study aimed to evaluate the effectiveness of contrast TTE as a routine screening method for detecting LV thrombus in the acute phase of anterior STEMI.

Conditions

  • Thrombus of Left Ventricle
  • Anterior Wall Myocardial Infarction
  • ST Elevation Myocardial Infarction
  • Echocardiography

Interventions

OTHER

Contrast TTE procedure, the SonoVue ultrasound agent

The intervention involved using contrast-enhanced transthoracic echocardiography (TTE) to improve the detection of left ventricular thrombus in patients with anterior ST-elevation myocardial infarction (STEMI).

Sponsors & Collaborators

  • Centro Hospitalar Tondela-Viseu

    lead OTHER

Principal Investigators

  • Joana ML Correia · 219827419

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06480929 on ClinicalTrials.gov